LabTurbo Biotech (ROCO:7725) Long-Term Capital Lease Obligation : NT$21.62 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LabTurbo Biotech Long-Term Capital Lease Obligation?

LabTurbo Biotech's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$21.62 Mil.

LabTurbo Biotech's quarterly Long-Term Capital Lease Obligation increased from Dec. 2023 (NT$7.62 Mil) to Jun. 2024 (NT$20.96 Mil) and increased from Jun. 2024 (NT$20.96 Mil) to Dec. 2024 (NT$21.62 Mil).

LabTurbo Biotech's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (NT$1.36 Mil) to Dec. 2023 (NT$7.62 Mil) and increased from Dec. 2023 (NT$7.62 Mil) to Dec. 2024 (NT$21.62 Mil).

LabTurbo Biotech Long-Term Capital Lease Obligation Historical Data

The historical data trend for LabTurbo Biotech's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabTurbo Biotech Long-Term Capital Lease Obligation Chart

LabTurbo Biotech Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

0.54

1.36

7.62

21.62

LabTurbo Biotech Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			1.36	-	7.62	20.96	21.62

LabTurbo Biotech (ROCO:7725) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

LabTurbo Biotech Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of LabTurbo Biotech's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

LabTurbo Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LabTurbo Biotech Corp (ROCO:7725) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN

Website

https://www.labturbo.com.tw

LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.

LabTurbo Biotech Headlines

No Headlines